Armata Pharmaceuticals Inc
For the period ended Jun 30, 2024. Filed Aug 13, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 13, 2024
ARMP$3.75-1.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ (Deficit) Equity
Three and Six Months Ended June 30, 2024 and 2023
(in thousands, except share data)
| | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · Stockholders’ Equity | ||||||||||||||
| · · Common Stock · · · · · · · · · | ||||||||||||||
| · · · · · · · Additional · · · · Total | ||||||||||||||
| · · · · · · · Paid-in · · Accumulated · · Stockholders’ | ||||||||||||||
| · Shares · Amount · Capital · Deficit · Equity | ||||||||||||||
| Balances, March 31, 2023 | 36,144,706 | | $361 | | $276,350 | | $(254,264) | | $22,447 | |||||
| Forfeiture of restricted stock awards | (3,699) | | | — | | | — | | | — | | | — | |
| Withholdings for taxes related to net share settlement of equity awards | | (13,701) | | | — | | | (18) | | | — | | | (18) |
| Share-based compensation expense | — | | | — | | | 261 | | | — | | | 261 | |
| Net loss | — | | | — | | | — | | | (3,547) | | | (3,547) | |
| Balances, June 30, 2023 | 36,127,306 | | $361 | | $276,593 | | $(257,811) | | $19,143 | |||||
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | Stockholders’ Deficit | ||||||||||||
| | | Common Stock | | | | | | | | | | |||
| | | | | | | | Additional | | | | Total | |||
| | | | | | | | Paid-in | | Accumulated | | Stockholders’ | |||
| | Shares | Amount | Capital | Deficit | Deficit | |||||||||
| Balances, March 31, 2024 | 36,132,117 | | $361 | | $276,969 | | $(333,840) | | $(56,510) | |||||
| Exercise of stock options | | 23,875 | | | 1 | | | 87 | | | — | | | 88 |
| Share-based compensation expense | — | | | — | | | 1,335 | | | — | | | 1,335 | |
| Net income | — | | | — | | | — | | | 8,986 | | | 8,986 | |
| Balances, June 30, 2024 | 36,155,992 | | $362 | | $278,391 | | $(324,854) | | $(46,101) | |||||
| | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · Stockholders’ Equity | ||||||||||||||
| · · Common Stock · · · · · · · · · | ||||||||||||||
| · · · · · · · Additional · · · · Total | ||||||||||||||
| · · · · · · · Paid-in · · Accumulated · · Stockholders’ | ||||||||||||||
| · Shares · Amount · Capital · Deficit · Equity | ||||||||||||||
| Balances, December 31, 2022 | 36,144,706 | | $361 | | $275,493 | | $(239,774) | | $36,080 | |||||
| Forfeiture of restricted stock awards | | (3,699) | | | — | | | — | | | — | | | — |
| Withholdings for taxes related to net share settlement of equity awards | | (13,701) | | | — | | | (18) | | | — | | | (18) |
| Stock-based compensation expense | — | | | — | | | 1,118 | | | — | | 1,118 | ||
| Net loss | — | | | — | | | — | | | (18,037) | | (18,037) | ||
| Balances, June 30, 2023 | 36,127,306 | | $361 | | $276,593 | | $(257,811) | | $19,143 | |||||
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | Stockholders’ Deficit | ||||||||||||
| | | Common Stock | | | | | | | | | | |||
| | | | | | | | Additional | | | | Total | |||
| | | | | | | | Paid-in | | Accumulated | | Stockholders’ | |||
| | | Shares | Amount | Capital | Deficit | Deficit | ||||||||
| Balances, December 31, 2023 | 36,122,932 | | $361 | | $276,393 | | $(308,819) | | $(32,065) | |||||
| Exercise of stock options | | 37,282 | | | 1 | | | 129 | | | — | | | 130 |
| Withholdings for taxes related to net share settlement of equity awards | | (4,222) | | | — | | | — | | | — | | | — |
| Stock-based compensation expense | | — | | | — | | | 1,869 | | | — | | | 1,869 |
| Net loss | — | | | — | | | — | | | (16,035) | | | (16,035) | |
| Balances, June 30, 2024 | 36,155,992 | | $362 | | $278,391 | | $(324,854) | | $(46,101) | |||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.